Functional Genomics and Drug Discovery: New Approaches for Decision Making
An executive education program at Harvard Medical School
There has been increasing interest and investment in applying genomics and related technologies to drug discovery and development. However, with the exception of a small number of well-recognized successes, much uncertainty remains about how to best leverage these tools throughout the pharmaceutical value chain. Led by renowned leaders from industry and academia, this new executive education program provides a unique opportunity to delve into the use of genomics in common and rare diseases, and throughout the drug discovery, development, regulatory, and post-regulatory phases. Pre-work, case-based teaching, and group work will ground insights in real-world applications.
The program is intended for mid- to senior-level scientific and business leaders who make operational, strategic or investment decisions related to drug discovery and development.